Page last updated: 2024-08-16

propranolol and alpha-synuclein

propranolol has been researched along with alpha-synuclein in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abo, KM; Bartels, T; Bjørnevik, K; Caldarone, BJ; Dong, X; Engeland, A; Flierl, A; Glicksman, MA; Heutink, P; Im, DS; Jin, M; Khurana, V; Locascio, JJ; Long, E; Mittal, S; Park, DS; Riise, T; Rizzu, P; Rochet, JC; Scherzer, CR; Schüle, B; Selkoe, DJ; Xiang, YK; Xu, B	1

Other Studies

1 other study(ies) available for propranolol and alpha-synuclein

Article	Year
β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease. Science (New York, N.Y.), 2017, 09-01, Volume: 357, Issue:6354 Topics: Acetylation; Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Antagonists; Albuterol; alpha-Synuclein; Animals; Cell Line, Tumor; Enhancer Elements, Genetic; Gene Expression Regulation; Histones; Humans; Ligands; Mice; Neuroprotective Agents; Norway; Parkinson Disease; Promoter Regions, Genetic; Propranolol; Receptors, Adrenergic, beta-2; Risk; Substantia Nigra; Transcription, Genetic	2017

Article

Year

β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease.

Science (New York, N.Y.), 2017, 09-01, Volume: 357, Issue:6354

Topics: Acetylation; Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Antagonists; Albuterol; alpha-Synuclein; Animals; Cell Line, Tumor; Enhancer Elements, Genetic; Gene Expression Regulation; Histones; Humans; Ligands; Mice; Neuroprotective Agents; Norway; Parkinson Disease; Promoter Regions, Genetic; Propranolol; Receptors, Adrenergic, beta-2; Risk; Substantia Nigra; Transcription, Genetic

2017